Product › Details

MassCode PCR technology

	Next higher product group	PCR technology_o
	Status	2010-12-08 sales existent
	Organisation	Agilent Technologies Inc. (NYSE: A)
	Group	Agilent (Group)

Shimadzu Biotech. (7/01). "Press Release: Shimadzu to Launch SNP Analysis Service. New Agreement Expands Genomic Services".

Shimadzu Corporation has entered into an agreement with QIAGEN NV's wholly-owned subsidiary, QIAGEN Genomics Inc (Seattle, USA) to launch its single nucleotide polymorphism (SNP) analysis service.

Under the non-exclusive five-year agreement, Shimadzu has purchased QIAGEN's Masscode system and licensed the related high-throughput SNP genotyping technology. The agreement allows Shimadzu to establish a further analysis service, complementing the DNA and protein analysis businesses already in place.

The Masscode system comprises a platform chemistry of cleavable mass spectrometry tags. A small molecular weight tagged oligonucleotide is used as a primer in an allele-specific PCR SNP discrimination assay. The allele-specific amplicons are differentiated through their Masscode tag assignments. Following a photolysis step to cleave the tags from the amplicon, the samples are introduced into a single quadrupole mass spectrometer detection system for analysis.

The system requires only very small DNA sample volumes and is equipped to cope with 15 SNPs per well in 96-well plates. Up to 40,000 SNP genotyping measurements can be performed per day and the digital read-out eliminates spectral overlap, making it a highly precise method for genomic analysis.

Initially, Shimadzu's plans to equip a facility in Japan able to conduct around 10,000 SNP analysis per day. Shimadzu has previously invested ¥0.25 billion in its SNP genotyping business, the launch of which is scheduled for October 2001.

- ends -

For more information, please contact:

Shimadzu Biotech
Dr Tetsuo Ichikawa, Chairman
Tel: 81-75-823-1148
Fax: 81-75-823-1364
email: tichi@shimadzu.co.jp
For press information, please contact:

HCC De Facto Group plc
Richard Anderson
Tel: +44 (0)20 7496 3310
Fax: +44 (0)20 7496 3355
s.black@hccdefacto.com

Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

MassCode PCR technology

Shimadzu Biotech. (7/01). "Press Release: Shimadzu to Launch SNP Analysis Service. New Agreement Expands Genomic Services".

More documents for PCR technology